Eudald Felip

11PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 27, 2024
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Iris Teruel, Eva Castellà, Sabela Recalde

|Jun 28, 2023
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer.

Laura Pons, Laura Hernández, Aintzane Urbizu

|Jan 08, 2023
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer-COVID Lung Vaccine Study.

Ainhoa Hernandez, Marc Boigues, Eudald Felip

|Dec 10, 2022
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.

Eudald Felip, Edwards Pradenas, Margarita Romeo

|Jul 27, 2022
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer.

Angelica Ferrando-Díez, Eudald Felip, Anna Pous

|Feb 15, 2022
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.

Eudald Felip, Lucía Gutiérrez-Chamorro, Maica Gómez

Pageof 2

Frequent Collaborators

5 joint publications

Mireia Margelí

3 joint publications

Iris Teruel

3 joint publications

Anna Martínez-Cardús

2 joint publications

Ifeanyi Jude Ezeonwumelu